| |
Name
|
Size
|
Creator |
Creation Date
|
Labels |
|
|
|
PDF File
2022-04-08 PASI V2 Annotated CRF.pdf
|
813 kB |
Steve Kopko |
Apr 08, 2022 09:39 |
|
|
| |
Version 1 (current)
|
813 kB |
Steve Kopko |
Apr 08, 2022 09:39 |
|
|
|
|
PDF File
QRS EMAIL 2022-04-08 CDISC QRS 1st Review Request PASI V2 V1.0.pdf
|
708 kB |
Steve Kopko |
Apr 08, 2022 10:27 |
|
|
| |
Version 1 (current)
|
708 kB |
Steve Kopko |
Apr 08, 2022 10:27 |
|
|
|
|
PDF File
2022-04-08 guideline-clinical-investigation-medicinal-products-indicated-treatment-psoriasis_en.pdf
|
246 kB |
Steve Kopko |
Apr 08, 2022 09:39 |
|
|
| |
Version 1 (current)
|
246 kB |
Steve Kopko |
Apr 08, 2022 09:39 |
|
|
|
|
PDF File
2022-04-08 PASI article_highlighted_with notes.pdf
|
143 kB |
Steve Kopko |
Apr 08, 2022 09:39 |
|
|
| |
Version 1 (current)
|
143 kB |
Steve Kopko |
Apr 08, 2022 09:39 |
|
|
|
|
PDF File
2022-04-08 PASI V2 reference.pdf
|
62 kB |
Steve Kopko |
Apr 08, 2022 09:39 |
|
|
| |
Version 1 (current)
|
62 kB |
Steve Kopko |
Apr 08, 2022 09:39 |
|
|
|
|
Microsoft Word Document
2022-04-06 SDTM RS-PASI V2 V1.0 Public Domain.docx
|
58 kB |
Steve Kopko |
Apr 08, 2022 09:39 |
|
|
| |
Version 1 (current)
|
58 kB |
Steve Kopko |
Apr 08, 2022 09:39 |
|
|
|
|
Microsoft Word Document
2022-04-08 CDISC QRS 1st Review Request PASI V2 V1.0.docx
|
23 kB |
Steve Kopko |
Apr 08, 2022 09:57 |
|
|
| |
Version 1 (current)
|
23 kB |
Steve Kopko |
Apr 08, 2022 09:57 |
|
|